MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder
Status:
Not yet recruiting
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
This randomized, double-blind, single-site phase II 2-arm study will investigate the safety
and preliminary efficacy of MDMA-assisted therapy compared with low dose
d-amphetamine-assisted therapy on the severity of PTSD symptoms in participants aged 18 years
and older with PTSD of at least moderate severity.